Pressure Biosciences, Target Discovery Partner on Tissue Prep | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure Biosciences and Target Discovery have struck a multi-faceted agreement covering the development, manufacture, and co-marketing of reagents, PBI said today.

Under the agreement, TDI has licensed PBI to make and sell a line of TDI reagents that were designed to be used with PBI's Pressure Cycling Technology for preparing tissues for scientific analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.